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SHORT COMMUNICATION / COMUNICAÇÃO
ABSTRACT
Citrus leprosis, caused by Citrus leprosis virus C (CiLV-C), is currently considered the most important viral disease in the Brazilian 
citrus industry due to the high costs required for the chemical control of its vector, the mite Brevipalpus phoenicis. The pathogen induces a 
non-systemic infection and the disease is characterized by the appearance of localized lesions on citrus leaves, stems and fruits, premature 
fruit and leaf drop and dieback of stems. Attempts were made to promote in vitro expression of the putative cell-to-cell movement protein 
of CiLV-C in Escherichia coli and to produce a specific polyclonal antibody against this protein as a tool to investigate the virus-plant-
vector relationship. The antibody reacted strongly with the homologous protein expressed in vitro by ELISA, but poorly with the native 
protein present in leaf lesion extracts from sweet orange caused by CiLV-C. Reactions from old lesions were more intense than those from 
young lesions. Western blot and in situ immunolocalization assays failed to detect the native protein. These results suggest low expression 
of the movement protein (MP) in host tissues. Moreover, it is possible that the conformation of the protein expressed in vitro and used to 
produce the antibody differs from that of the native MP, hindering a full recognition of the latter.
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Citrus leprosies, caused by Citrus leprosis virus C 
(CiLV-C), is considered one of the most important diseases 
for the citrus industry in the Americas. Sweet orange 
varieties [Citrus sinensis (L.) Osbeck] are highly susceptible 
to the virus, and plants may be completely destroyed if 
left untreated (Müller et al., 2005). In Brazil, around US$ 
100 million are spent annually for the chemical control 
of its vector, the false spider mite Brevipalpus phoenicis 
(Geijskes) (Acari: Tenuipalpidae) (Bastianel et al., 2006). 
The disease symptoms are characterized by chlorotic or 
necrotic local lesions on the leaves, stems and fruit at the mites’ 
feeding areas. Furthermore, it can lead to heavy losses due to 
the drop of leaves and fruits and, eventually, the premature 
death of the trees (Bastianel et al., 2010). CiLV-C, recently 
classified as the type species of a new genus of plant viruses, 
Cilevirus (Carstens, 2010), has a bipartite genome composed 
by two ssRNA molecules of positive polarity (Locali-Fabris et 
al., 2006; Pascon et al., 2006). RNA 1 (8745 nucleotides - nt) 
contains two open reading frames (ORFs), which potentially 
encode 286 and 29 kDa proteins. The 286 kDa protein is a 
polyprotein putatively involved in virus replication, and the 
29 kDa protein is the putative coat protein of CiLV-C. RNA 
2 (4986 nt) contains four ORFs which potentially encode, 
respectively, 15, 61, 32 and 24 kDa proteins. Among these, 
only the 32 kDa protein, encoded by ORF 3, has a putative 
function assigned, apparently being involved in cell-to-cell 
movement of the virus (Locali-Fabris et al., 2006; Pascon 
et al., 2006).
Despite the sequencing of the CiLV-C genome, 
there is still lack of essential information about the leprosis 
pathosystem such as the infection and replication processes 
of the virus in the hosts, the precise virus/vector relationship 
and the reasons for the absence of systemic infection. Thus, 
the studies involving analyses of the expression of viral 
proteins in the host cells consist in one of the strategies 
to better understand the interactions that occur between 
the virus and its hosts (Hull, 2002). One alternative for 
the study of virus/host/vector relationship is to follow the 
expression of viral genes using immunological techniques 
based on antibodies produced against the different viral 
proteins. Unfortunately, traditional methods to raise 
antibodies against viral structural proteins using purified 
virus preparations have been unsuccessful for CiLV-C due 
to the low viral titer in the plant tissues and the instability 
of the particles (Colariccio et al., 2000). A way to overcome 
such difficulties is to use viral proteins expressed in vitro as 
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immunogens (Zerbini et al., 2002). As part of the strategies 
to advance in studies related with in situ detection of the virus 
proteins, we attempted to promote the in vitro expression of 
the ORF 3, the putative viral movement protein (MP) of 
CiLV-C, and to produce a specific polyclonal antibody. This 
antibody would serve to detect the MP in infected plants by 
PTA-ELISA, Western blot and in situ immunolocalization. 
MPs are present in the genomes of most plant viruses 
and are implicated in cell-to-cell movement of the infectious 
material associated with the plasmodesmata (Wolf et al., 
1989; Deom et al., 1990; Haupt et al., 2005; Akamatsu et 
al., 2007). In the CiLV-C pathosystem, there is a particular 
interest to follow the MP expression and its fate in the plant 
cells to understand why the infection is localized and not 
systemic. It is important to point out that most of the studies 
related to MPs are concentrated in their function or loss of 
function through mutations, production of transgenic plants, 
cellular localization and increasing of the size exclusion 
limit of the plasmodesmata, and interaction with other 
proteins in protoplasts cells (Wolf et al., 1989; Deom et al., 
1990; Haupt et al., 2005; Akamatsu et al., 2007). Moreover, 
the peculiarity of MPs as non structural proteins contributes 
to the scarcity of studies related to antibody production and 
in vivo detection. 
The dsRNA extraction from leaf lesions and cDNA 
syntheses were performed according to the protocols 
described by Locali et al. (2003). The full-length sequence 
of ORF 3 (gb_DQ352194) was amplified using 3 μL of 
cDNA, 2.5 μL of 10x buffer, 0.9 μL of 50 mM MgCl
2
, 0.5 
μL of 2.5 mM dNTP mix, 0.5 μL of each specific primer (10 
μM) , 0.2 μL (1.5 U) of Taq DNA polymerase (Invitrogen) 
and sterile Milli-Q water to 25 μL final volume. The primers 
used for the complete mp amplification were: MP forward 
(5’CAC CAT GGC TCT TTC TAC CAA TAA CAA3’), MP 
reverse (5’TTA TTC GCT TGT AGA AGT TGA GC3’). The 
reaction was performed using a PTC 100 (MJ Researcher, 
Walthan, MA) thermocycler programmed for 30 cycles of 
denaturation at 94ºC for 30 s, annealing at 56ºC for 30 s and 
extension at 72ºC for 40 s. A final 5 minutes extension at 72ºC 
was added to the last cycle. PCR products were visualized in a 
1% agarose gel containing 0.5 μg ethidium bromide mL-1.
Cloning was performed using the Gateway 
technology (Invitrogen), following manufacturer’s 
instructions. At first, the MP amplicon was cloned into 
the entry vector using the pENTR Directional TOPO 
Cloning kit (Invitrogen), and then transferred to pDEST17 
according to the manufacturer’s instructions. The clones of 
pDEST17/mp were confirmed by PCR and sequencing. The 
pDEST17/mp plasmid was extracted from E. coli DH5α 
by the alkaline lysis method (Sambrook et al., 1989) and 
three E. coli strains, BL21-DE3, BL21-DE3-pLysS and 
BL21-DE3-RP, were transformed (Sambrook et al., 1989) 
using 10 ng of plasmid DNA, to select the most efficient 
strain for in vitro protein expression. The selected strain 
BL21-pLysS/mp was grown in 500 mL of 2xYT medium 
with 100 mg/L of ampicillin and chloramphenicol at 37ºC 
until O.D.
600 
equal to 0.6. At that moment, it was added 0.2 
mM of IPTG and, after 3 hours, the whole volume was 
transferred to centrifuge tubes and centrifuged at 5,000 rpm 
(Beckman F0650 rotor) for 12 min at 4ºC. The supernatants 
were discarded and the tubes with the bacterial pellets were 
stored at -80ºC.
Two tubes containing pellets from BL21-pLysS/mp 
cells were resuspended in 8 mL of lysis buffer (Tris 50 mM, 
EDTA 1 mM, β-2-mercaptoetanol 14 mM, 25% sacarose, 
pH 8.5) each and the final volume submitted to physical 
lysis by “French Pressure Cell Press” (SLM AMINCO, 
SLM Instruments, Inc). The solution was centrifuged at 
15,000 rpm (Beckman F0650 rotor) for 30 min at 4ºC, and 
the supernatant (soluble protein fraction) was collected 
to be analyzed for the presence of the MP protein by 
SDS-PAGE. The precipitate was resuspended in 20 mL 
of solubilization buffer (Urea 6 M, Tris 50 mM, EDTA 
1 mM, β-2-mercaptoetanol 14 mM, pH 8.5), homogenized 
and incubated for 50 min under slow agitation at room 
temperature. After that, the solution was centrifuged at 
15,000 rpm (Beckman F650 rotor) for 40 min at 4ºC and 
the supernatant (insoluble protein fraction) collected to be 
analyzed for the presence of the MP by SDS-PAGE and mass 
spectrometry in a Q-TOF-Ultima API mass spectrometer 
(Waters). 
For MP purification, the insoluble protein fraction 
was initially submitted to two consecutive purifications 
by ion exchange chromatography using, at first, an SQ 
Sepharose column (GE Healthcare) followed by an SP 
Sepharose column (GE Healthcare). A third purification by 
affinity chromatography with immobilized metal was carried 
out with a HisTrap HP column (GE Healthcare), according 
to the manufacturer’s instructions. The fraction containing 
the MP was quantified by measuring the absorbance at 280 
nm. 
The immunization program consisted of six 
injections. Once a week, 200 μg of pure MP were injected 
in a New Zealand rabbit. The first dose was prepared using 
a 1:1 ratio (v/v) of MP to complete Freund’s adjuvant, 
and it was injected by subcutaneous form in the dorsum 
of the rabbit, after collecting the pre-immune bloody. The 
subsequent doses were injected as described above, but 
using incomplete Freund’s adjuvant.
PTA-ELISA was carried out as described by Mowat 
& Dawson (1987) using symptomatic leaf lesions from Pêra 
sweet oranges at different levels of disease development 
(Figure 1). Samples were visually separated into three 
categories: young lesions (YL), intermediary lesions (IL) 
and old lesions (OL) and were tested in a 1:50 dilution 
(w/v) with the MP antibody diluted at 1:1000. Further tests 
were conducted using OL samples diluted at 1:30, 1:20 and 
1:10 (w/v) and the MP antibody diluted at 1:800, 1:400, 
1:200 and 1:100 (v/v). Tissues from healthy plants at the 
same dilutions were used as negative controls. The samples 
analyzed by Western blot were the same used for PTA-ELISA 
but, in this case, they were ground in 0.5 M tris-HCl buffer 
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pH 6.8 in a 1:3 ratio (w/v). The procedure was carried out 
as described by Barbosa-Mendes (2007) with the antibody 
diluted at 1:200 (v/v). For in situ immunolocalization assays, 
fragments of leaf lesions from sweet orange infected with 
CiLV-C were fixed in a modified Karnovsky solution (2.5% 
glutaraldehyde, 2% paraformaldehyde in 0.05 M, pH 7.2 
cacodylate buffer), dehydrated in ethanol and embedded in 
LR White resin. Ultrathin sections (70 nm) were mounted 
on nickel grids and immunolabelled using the protocol of 
Maunsbach & Afzelius (1999) with the MP antibody diluted 
at 1:100 and 1:1000 (v/v). Specimens were examined in a 
Zeiss EM 900 transmission electron microscope. Healthy 
sweet orange tissues were used as controls.
The RT-PCR amplified product, herein referred to as 
mp, presented the expected size of ca. 890 bp. Several pENTR 
D-TOPO/mp clones were obtained, some of which revealed 
to contain the 890 bp fragment by PCR. Sequencing of the 
vector confirmed that the fragment was cloned in the correct 
orientation without nucleotide changes. The clone selected 
presented an 98% identity with the CiLV-C isolate from 
Cordeirópolis (DQ352194 for RNA 2). Subsequent cloning 
of the amplicon into pDEST17 was confirmed by PCR and 
bacterial growth in the presence of chloramphenicoland. 
The clone selected for protein expression was verified for 
the presence of the Shine-Delgarno sequence and the six 
aligned histidines.
The MP expression levels obtained for the different 
E. coli BL21 strains tested showed no significant difference. 
The expressed protein had a molecular mass of ca. 35 kDa, 
close to the value of 32.5 kDa estimated by Locali-Fabris et 
al. (2006) for the CiLV-C putative movement protein. The 
difference of 2.5 kDa on the in vitro MP mass is due to the six 
histidine tag of the recombinant MP. BL21-DE3-pLysS was 
the selected strain for large scale expression because of its 
capacity to suppress the basal expression of the T7 promoter 
due to the production of T7 lysozyme, a natural inhibitor of 
T7 RNA polymerase. The extraction of the expressed protein 
from E. coli BL21-DE3-pLysS cells demonstrated that the 
MP was present only in the insoluble fraction, probably as 
the result of inclusion bodies formation (Martínez-Alonso 
et al., 2009). Similar cases of insolubility of proteins 
expressed in E. coli system were reported with the replicases 
of Tobacco mosaic virus (TMV) and Citrus tristeza virus 
(CTV) (Hills et al., 1987; Çevik et al., 2008) and with TMV 
MP (Chen et al., 2000). The formation of inclusion bodies is 
not correlated with the size of the synthesized polypeptide, 
the use of a fusion construct, the subunit structure, or 
the relative hydrophobicity of the recombinant protein. 
Overproduction by itself can be sufficient to induce the 
formation of these inclusions (Schumann & Ferreira, 2004). 
Attempts to prevent the formation of inclusion bodies by 
growing bacterial cultures at low temperature (14ºC) were 
unsuccessful (R.F. Calegario, unpublished data). On the 
other hand, the use of urea during MP extraction from the 
insoluble fraction solubilizes the protein but could result 
in its undesirable denaturation. This process is highly 
relevant for antibody production due to the possibility of 
losing the original three-dimensional conformation of the 
protein, which can lead to a problem in recognition of the 
native MP in infected plants by the antibody produced. A 
similar problem occurred in our attempt to in vitro express 
the helicase domain of CiLV-C RdRp using the same vector 
system (R.F. Calegario, unpublished data). The sequencing 
by mass spectrometry of MP purified from the insoluble 
FIGURE 1 - Leaves from Pêra sweet orange infected by CiLV-C at different levels of disease development. 1, Healthy; 2, Young lesions 
(YL) ; 3, Intermediary lesions (IL); 4, Old lesions (OL).
1                                           2                                             3                                                4
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fraction indicated the identity with the CiLV-C p32 protein 
(DQ352194) and thus confirmed the success of the in vitro 
expression of the putative CiLV-C MP. Expressed MP was 
purified from the insoluble fraction by three sequential 
steps, the last of which required a HisTrap HP system and 
resulted in a highly purified and concentrated protein, with 
1.25 mg/mL in the eluted fraction (Figure 2).
The produced antibody reacted specifically with the 
injected protein by PTA-ELISA. The same assay, using 
extracts of symptomatic sweet orange leaves as antigens 
diluted 1:50 and anti-MP serum diluted 1:1000, also 
resulted positive. It was noticed that, as a rule, older lesions 
yielded a stronger reaction compared to younger lesions. 
No significant reaction was observed in extracts from 
uninfected, control leaves. 
Further assays showed that immunodetection of MP 
may sometimes be erratic, suggesting that MP concentration 
is likely to be low in infected tissues. This has already been 
noticed in the detection of CiLV-C by RT-PCR, when larger 
chlorotic lesions were more appropriate than necrotic lesions 
(Antonioli-Luizon et al., 2004). CiLV-C detection in the 
tissues by transmission electron microscopy also revealed 
that while in younger small lesions most of the cells were 
infected, in older larger lesions the virus could be detected 
only in a few parenchymal cells (Gomes et al., 2004). 
Different dilutions of the antigen and antibody were 
tested to find an optimal combination for MP detection, 
considering a possible diagnostic application. Older 
CiLV-C lesions from infected Pêra sweet orange were used 
as antigens, since preliminary data indicated better PTA-
ELISA results for that kind of sample. The results indicate 
that MP can be detected in mature leaf lesions from CiLV-
C-infected Pêra sweet orange by PTA-ELISA. The optimal 
conditions for the diagnosis are 1:10 to 1:20 dilution of 
the leaf extract and 1:100 to 1:200 dilution of the anti-MP 
serum (Table 1). Because of its limited sensitivity, anti-MP 
antiserum may not be appropriate for diagnostic purposes. 
Indeed, the recent development of a highly selective and 
reactive anti-p29 (the putative capsidal protein) of CiLV-C 
has allowed the immunodetection of this virus and can be 
used for disease diagnosis (Locali-Fabris et al., 2008). 
Pure expressed MP was efficiently detected by the 
anti-MP serum in Western blot assays. However, similar tests 
carried out using extracts from symptomatic sweet orange 
leaves were unsuccessful. Also, in situ immunolocalization 
assays failed to detect the native MP. No significant labeling 
by anti-MP antibody was observed in CiLV-C infected tissues. 
A possible explanation for these failures is that MP has high 
hydrophobicity and is associated with membranes of the 
host cell (Chen et al., 2000). Such circumstances make its 
solubilization difficult, even after boiling the samples. Another 
hypothesis is that the expressed protein undergoes a different 
post-translational folding, resulting in completely different 
epitopes compared to the native MP protein. Or, alternatively, 
the expressed protein may be properly folded but suffers 
alterations during the extraction procedure from the insoluble 
protein fraction. Finally, the amount of MP present in the tissues 
may be very low, as suggested by preliminary RT-qPCR studies 
following the expression of different CiLV-C ORFs during the 
evolution of the infection, in which expression of ORF 3 
goes almost unnoticed (Nicolini-Teixeira et al., 2008). 
FIGURE 2 - SDS-PAGE of pure movement protein obtained 
after purification with the HisTrap HP column. M, Broad range 
molecular weight markers (BioRad); 1, Insoluble protein extract, 
5 µL (1:3 dilution of insoluble protein to buffer); 1 and 2, Pure MP 
in the eluted fraction after purification, 10 µL (2:1 dilution of MP 
protein to buffer).
Leaf extract dilutionAnti-MP
antiserum
dilution
1:10 1:20 1:30
Control (-) Infected (+) Control (-) Infected (+) Control (-) Infected (+)
1:100 - - 0.301 0.623 0.300 0.,466
1:200 0.230 0.500 0.200 0.420 0.198 0.310
1:400 0.111 0.283 0.100 0.231 0.095 0.173
1:800 0.068 0.176 0.07 0.141 - -
TABLE 1 - Absorbance values (405 nm) obtained in PTA-ELISA. 1:10, 1:20 or 1:30, Ratio between leaf extracts from old lesions or 
healthy leaves to carbonate buffer (w/v). Reaction time: 3 hours after substrate addition
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As a conclusion, the fact that CiLV-C does not infect 
its hosts systemically can be related with the involvement 
of inhibition mechanisms in the viral passage to the phloem, 
not being possible to discard some difficulty in its replication 
or in its cell-to-cell movement to the vascular region. There 
is, in addition, the hypothesis of a possible gene silencing 
mechanism taking place, what would hinder the detection of 
the MP transcripts. These results demonstrate the complexity 
of genetics and biochemical mechanisms involved in the 
citrus leprosis pathosystem, but open the possibility for 
further steps towards  the development of other interaction 
studies which can use the purified MP as a tool. 
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